Brad Glick, DO, MPH
Program Director, Dermatology Residency, Larkin Health System, Palm Springs Campus; Assistant Clinical Professor of Dermatology, Herbert Wertheim College of Medicine, Miami, Florida
South/South_Atlantic, FL
Disclosure
Advisory Board: AbbVie, Advisory Boards - South Beach Symposium, Amgen, Apogee Therapeutics, Arcutis, Inc., Bristol-Myers Squibb, Castle Biosciences, Inc, CLn Skin Care, Dermaleve, Dermavant Sciences, Inc., Dermira, Eli Lilly and Company, Evelo Biosciences, Inc., Incyte Corporation, Janssen Biotech, Johnson & Johnson, LEO Laboratories Ltd (LEO Pharma), Lilly ICOS LLC, Lyceum Health, MC2 Therapeutics, Novartis Pharmaceuticals Corp., Nutrafol, NuVida, Ortho Dermatologics, Oruka Therapeutics, Pelthos Therapeutics, Pfizer Inc., Primus Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Sanofi Genzyme, Sensus Healthcare, Skin Angels, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceuticals USA Inc, UCB, VeraDermics Inc., Verrica Pharmaceuticals Inc, Vial
Consultant: Boehringer Ingelheim, Noven Pharmaceuticals
Grant/Research Support: AbbVie, Alumis, Amgen, Apogee Therapeutics, Arcutis, Inc., AstraZeneca, Attovia Therapeutics, Bellus Medical, Bluefin Biomedicine, Botanix Pharmaceuticals, Brickell Biotech, Inc., Bristol-Myers Squibb, Cara Therapeutics, Catawba Research, LLC, Celgene, Celldex, ChemoCentryx, Clexio Biosciences, Ltd, CoreEvitas, LLC, Corrona, Inc., Dermavant Sciences, Inc., Dermira, Eli Lilly and Company, Galderma Laboratories, L.P., GSI Clinical Research, LLC, Incyte Corporation, Indero, Inc., Innovaderm Research Inc., Insmed, IQVIA, Janssen Biotech, Janssen Research & Development, LLC, Johnson & Johnson, Lilly ICOS LLC, MetaOptima, MoonLake Immunotherapeutics, Nimbus Therapeutics, Obagi Medical, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Prose, RAPT Therapeutics, Regeneron Pharmaceuticals, Inc., Sanofi Genzyme, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceuticals USA Inc, University of Pennsylvania, Xencor
Speakers’ Bureau or Honoraria: AbbVie, Almirall, American Osteopathic College of Dermatology, Amgen, Bausch Health, Botanix Pharmaceuticals, Bristol-Myers Squibb, CLn Skin Care, Derm Education Foundation, Dermatology Times (MMM MultiMedia Medical, LLC), Dermatology Week, Dermavant Sciences, Inc., Dermira, Eli Lilly and Company, Galderma Laboratories, L.P., Galderma USA, Hidradenitis Suppurativa Foundation, Hikma Pharmaceuticals, Incyte Corporation, international, IQVIA, Janssen Pharmaceuticals, Inc, Johnson & Johnson, Kyowa Kirin, Larkin Community Hospital Palm Springs Campus, Leo Pharma Inc, LEO Pharma, US, Lilly ICOS LLC, LiVDerm, MJH Life Sciences, National Psoriasis Foundation, Nova Southeastern University College of Osteopathic Medicine, Novartis Pharmaceuticals Corp., Ortho Dermatologics, Parexel, PEERView, Pelthos Therapeutics, Pfizer Inc., Prim-Med, RBC Wealth Management, Regeneron Pharmaceuticals, Inc., Sanofi Genzyme, Sensus Healthcare, Society of Dermatology Physician Assistants, Strata Skin Sciences, SUN Capital, LLC (Board of Directors), Sun Pharmaceutical Industries Ltd., Taisho Pharmaceuticals Co., Ltd., UCB
Other Financial Benefit: B.A.I. Biosciences (speaker), Florida Academy of Dermatology (Board of Directors), National Psoriasis Foundation (Board of Directors), Glick Skin Institute (Founder), Ohio University Heritage College of Osteopathic Medicine (speaker/faculty education)
Ownership Interest (privately held): Platinum Dermatology Partners (private company stock)
Ownership Interest (publicly traded): Platinum Dermatology Partners (Board of Directors, stock options), Stratum Biosciences (stock options), TopMD (stock)